(AMLX) Amylyx Pharmaceuticals - Performance 238.4% in 12m

AMLX performance: live returns, drawdowns, peer ranking & SPY comparison from 1w to 5y, all in one clean chart-driven dashboard.

Performance Rating -37.24%
#92 in Peer-Group
Rel. Strength 98.08%
#144 in Stock-Universe
Total Return 12m 238.38%
#7 in Peer-Group
Total Return 5y -65.36%
#113 in Peer-Group
P/E Value
P/E Trailing -
P/E Forward 2.77
High / Low USD
52 Week High 7.03 USD
52 Week Low 1.65 USD
Sentiment Value
VRO Trend Strength +-100 87.31
Buy/Sell Signal +-5 0.00
Support / Resistance Levels
Support
Resistance
12m Total Return: AMLX (238.4%) vs XLV (-7.1%)
Total Return of Amylyx Pharmaceuticals versus its related sector ETF XLV
5y Drawdown (Underwater) Chart
5 Year Drawdown / Underwater Chart for (AMLX) Amylyx Pharmaceuticals - Performance 238.4% in 12m

Top Performer in Pharmaceuticals

Short Term Performance

Symbol 1w 1m 3m
AMLX 22.8% 32.6% 65.6%
NKTR 238% 188% 132%
PHAT -12.1% 133% 49.9%
EYPT 18.2% 76.9% 68.9%

Long Term Performance

Symbol 6m 12m 5y
AMLX 53.8% 238% -65.4%
VRNA 104% 532% 1,995%
ALTS 117% 332% 213%
CRMD 76.1% 258% 143%

Overall best picks of Peer Group - Selected by proven GARP Predictive Metrics, sorted by Growth Rating

Symbol 1m 12m 5y P/E P/E Forward PEG EPS Stability EPS CAGR
CORT NASDAQ
Corcept Therapeutics
-3.67% 143% 342% 61.3 55.3 0.61 23.7% -5.15%
LLY NYSE
Eli Lilly
9.25% -11.8% 416% 63.7 36 1.2 58.2% 18.9%
NVS NYSE
Novartis
4.23% 13.9% 74.9% 18.5 14 1.37 8.70% 9.2%
NOVN SW
Novartis
1.41% 2.61% 46.8% 18.7 14.1 1.38 9.80% 11.2%
GSK NYSE
GlaxoSmithKline
-2.94% -0.85% 47.7% 19.9 9.2 0.4 -25.2% 3.11%
SFZN SW
Siegfried Holding
-7.61% -1.2% 117% 26.1 25 1.48 77.8% 77.6%
AZN NASDAQ
AstraZeneca
-1.8% -10.9% 47.7% 28.5 15.7 0.95 52.7% 22.3%
IPN PA
Ipsen
1.16% -10.2% 43.5% 24.1 10.2 0.73 -6.40% -6.33%

Performance Comparison: AMLX vs XLV vs S&P 500

XLV (Health Care Sector SPDR ETF) is the Sector Benchmark for AMLX
Total Return (including Dividends) AMLX XLV S&P 500
1 Month 32.63% 1.80% 3.01%
3 Months 65.61% -7.39% 5.82%
12 Months 238.38% -7.13% 12.82%
5 Years -65.36% 47.29% 114.16%

Trend Score (consistency of price movement) AMLX XLV S&P 500
1 Month 58% 54% 78.3%
3 Months 78% -57.4% 87.1%
12 Months 65.4% -69.2% 43.5%
5 Years -70.2% 88.1% 84%

Relative Strength (compared with Indexes) Rank in Peer Group vs. XLV vs. S&P 500
1 Month #15 30.28% 28.76%
3 Month #14 78.82% 56.51%
12 Month #8 264.35% 199.92%
5 Years #104 -67.14% -74.70%

FAQs

Does Amylyx Pharmaceuticals (AMLX) outperform the market?

Yes, over the last 12 months AMLX made 238.38%, while its related Sector, the Health Care Sector SPDR (XLV) made -7.13%. Over the last 3 months AMLX made 65.61%, while XLV made -7.39%.

Performance Comparison AMLX vs Indeces and Sectors

Above 0 means better perfomance compared to Symbol in this Timeframe

AMLX vs. Indices

Symbol 1w 1m 6m 12m
US S&P 500 SPY 20.8% 29.6% 52.2% 226%
US NASDAQ 100 QQQ 20.3% 28.7% 51.4% 225%
German DAX 40 DAX 22% 35.7% 36.6% 210%
Shanghai Shenzhen CSI 300 CSI 300 19.2% 28.4% 51.7% 219%
Hongkong Hang Seng HSI 18.4% 24.4% 33.2% 203%
India NIFTY 50 INDA 20.5% 31.8% 50.5% 238%
Brasil Bovespa EWZ 24.6% 32.3% 30.2% 232%

AMLX vs. Sectors

Symbol 1w 1m 6m 12m
Communication Services XLC 20.8% 29.1% 47% 215%
Consumer Discretionary XLY 21.3% 34.2% 62.2% 219%
Consumer Staples XLP 22.3% 34.5% 51.9% 232%
Energy XLE 26% 29.6% 52.3% 243%
Financial XLF 20% 31.3% 48.4% 212%
Health Care XLV 21.8% 30.8% 57.1% 246%
Industrial XLI 21.3% 32% 46.1% 219%
Materials XLB 22.5% 32.6% 51.1% 239%
Real Estate XLRE 23.3% 31.9% 51.4% 226%
Technology XLK 19.4% 25.1% 49.9% 228%
Utilities XLU 22.1% 33.4% 46.8% 218%
Aerospace & Defense XAR 20.1% 27.9% 35.4% 194%
Biotech XBI 22% 27.6% 63.9% 249%
Homebuilder XHB 18.8% 32.4% 62.2% 242%
Retail XRT 22.3% 32.3% 59.9% 236%

AMLX vs. Commodities

Symbol 1w 1m 6m 12m
Oil USO 33.6% 23.7% 53.6% 245%
Natural Gas UNG 35.1% 39.8% 50.7% 255%
Gold GLD 23.8% 31.8% 27.5% 195%
Silver SLV 23.5% 23.4% 32.2% 213%
Copper CPER 21.1% 28.6% 34.6% 225%

AMLX vs. Bonds

Symbol 1w 1m 6m 12m
iShares 20+ Years Bond TLT 21.8% 30.2% 52.4% 242%
iShares High Yield Corp. Bond HYG 22% 31.3% 49.7% 229%